share_log

Anebulo Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Cunningham, Richard Anthony

SEC ·  Oct 11, 2023 17:25
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more